نتائج البحث

المساهمون: Kon, H., Hameir, A., Nutman, A., Temkin, E., Paz, A. K., Lellouche, J., Schwartz, D., Weiss, D. S., Kaye, K. S., Daikos, G. L., Skiada, A., Durante-Mangoni, E., Benattar, Y. D., Yahav, D., Daitch, V., Bernardo, M., Iossa, D., Friberg, L. E., Theuretzbacher, U., Leibovici, L., Dickstein, Y., Pollak, D., Mendelsohn, S., Paul, M., Carmeli, Y.

مصطلحات موضوعية: carbapenem-resistance, colistin, heteroresistance, KEYWORDS Acinetobacter baumannii, population analysis profiling

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37219426; info:eu-repo/semantics/altIdentifier/wos/WOS:000996688700001; volume:11; issue:3; firstpage:e0509322; journal:MICROBIOLOGY SPECTRUM; https://hdl.handle.net/11591/514636Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85163913872

الإتاحة: https://doi.org/10.1128/spectrum.05093-22Test
https://hdl.handle.net/11591/514636Test

View record in BASE

4

دورية أكاديمية

Long COVID sexual dysfunction among both genders: Evaluation of a cohort of COVID-19 recoverees

المؤلفون: Yelin, D., Daitch, V., Kalfon, T., Mor, M., Buchrits, S., Shafir, Y., Awwad, M., Ghantous, N., Shapira-Lichter, I., Leibovici, L., Yahav, D., Margalit, I.

المصدر: Infectious Diseases Now ; volume 53, issue 7, page 104750 ; ISSN 2666-9919

مصطلحات موضوعية: Infectious Diseases

الإتاحة: https://doi.org/10.1016/j.idnow.2023.104750Test
https://api.elsevier.com/content/article/PII:S2666991923001124?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666991923001124?httpAccept=text/plainTest

View record in BASE

5

دورية أكاديمية

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility

المساهمون: Pfizer, Achaogen, Rempex, MSD, Gilead, bioMérieux, AbbVie, Sanofi-Aventis, Medtronic, DiaSorin, AstraZeneca, Allecra Therapeutics, DaVoltera, Intercell AG, bioMérieux SA, Rempex Pharmaceuticals, Nariva, Achoagen, Roche, Shionogi, European Commission

المصدر: Clinical Microbiology and Infection ; volume 25, issue 6, page 711-716 ; ISSN 1198-743X

الإتاحة: https://doi.org/10.1016/j.cmi.2018.09.014Test
https://api.elsevier.com/content/article/PII:S1198743X18306360?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1198743X18306360?httpAccept=text/plainTest

View record in BASE

6

دورية أكاديمية

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity

المساهمون: Daitch, V., Paul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., Zusman, O., Antoniadou, A., Cavezza, G., Adler, A., Dickstein, Y., Pavleas, I., Zampino, R., Bitterman, R., Zayyad, H., Koppel, F., Zak-Doron, Y., Levi, I., Babich, T., Turjeman, A., Ben-Zvi, H., Friberg, L. E., Mouton, J. W., Theuretzbacher, U., Leibovici, L.

مصطلحات موضوعية: Antibiotic treatment, Antimicrobial resistance, Population external validity, Acinetobacter Infection, Acinetobacter baumannii, Aged, Anti-Bacterial Agent, Carbapenem, Colistin, Female, Greece, Human, Israel, Italy, Logistic Model, Male, Meropenem, Middle Aged, Randomized Controlled Trials as Topic, Treatment Outcome, Drug Resistance, Bacterial

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33789574; info:eu-repo/semantics/altIdentifier/wos/WOS:000636461700001; volume:21; issue:1; firstpage:309; journal:BMC INFECTIOUS DISEASES; http://hdl.handle.net/11591/451117Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103746047

الإتاحة: https://doi.org/10.1186/s12879-021-05995-yTest
http://hdl.handle.net/11591/451117Test

View record in BASE

7

دورية أكاديمية

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

المؤلفون: Nutman A., Lellouche J., Temkin E., Daikos G., Skiada A., Durante Mangoni E., Dishon-Benattar Y., Bitterman R., Yahav D., Daitch V., Bernardo M., Iossa D., Zusman O., Friberg L. E., Mouton J. W., Theuretzbacher U., Leibovici L., Paul M., Carmeli Y., Benattar Y. D., Dickstein Y., Zayyad H., Koppel F., Zak-Doron Y., Altunin S., Andria N., Neuberger A., Stern A., Petersiel N., Raines M., Karban A., Eliakim-Raz N., Elbaz M., Atamna H., Babich T., Adler A., Levi I., Daikos G. L., Pavleas I., Antoniadou A., Kotsaki A., Andini R., Cavezza G., Bertolino L., Giuffre G., Giurazza R., Cuccurullo S., Galdo M., Murino P., Cristinziano A., Corcione A., Zampino R., Pafundi P. C., Mouton J., Friberg L., Kristoffersson A.

المساهمون: Nutman, A., Lellouche, J., Temkin, E., Daikos, G., Skiada, A., Durante Mangoni, E., Dishon-Benattar, Y., Bitterman, R., Yahav, D., Daitch, V., Bernardo, M., Iossa, D., Zusman, O., Friberg, L. E., Mouton, J. W., Theuretzbacher, U., Leibovici, L., Paul, M., Carmeli, Y., Benattar, Y. D., Dickstein, Y., Zayyad, H., Koppel, F., Zak-Doron, Y., Altunin, S., Andria, N., Neuberger, A., Stern, A., Petersiel, N., Raines, M., Karban, A., Eliakim-Raz, N., Elbaz, M., Atamna, H., Babich, T., Adler, A., Levi, I., Daikos, G. L., Pavleas, I., Antoniadou, A., Kotsaki, A., Andini, R., Cavezza, G., Bertolino, L., Giuffre, G., Giurazza, R., Cuccurullo, S., Galdo, M., Murino, P., Cristinziano, A., Corcione, A., Zampino, R., Pafundi, P. C., Mouton, J., Friberg, L., Kristoffersson, A.

مصطلحات موضوعية: Carbapenem resistance, Checkerboard assay, Colistin, Combination treatment, Gram-negative infections synergism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32251844; info:eu-repo/semantics/altIdentifier/wos/WOS:000560393000017; volume:26; issue:9; firstpage:1185; lastpage:1191; numberofpages:7; journal:CLINICAL MICROBIOLOGY AND INFECTION; http://hdl.handle.net/11591/429691Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084199137

الإتاحة: https://doi.org/10.1016/j.cmi.2020.03.035Test
http://hdl.handle.net/11591/429691Test

View record in BASE